{"schema_version":"secwatch.filing_event.v1","accession":"0001830214-25-000009","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2025-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.203656+00:00","generated_at":"2026-05-17T08:21:10.007899+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Ginkgo Bioworks enters $100M at-the-market equity sales agreement with Allen & Company","bullets":["Up to $100M in Class A common stock may be sold through Agent Allen & Company.","Agent receives commission of up to 3% of gross proceeds from each sale.","Registration statement on Form S-3 declared effective August 14, 2025; prospectus supplement dated Sept 4, 2025.","Net proceeds to be used for general corporate purposes including operations, tech development, working capital.","Company may terminate Sales Agreement with sufficient written notice; no assurance any shares will be issued."],"urls":{"canonical":"https://secwatch.observer/filing/0001830214-25-000009","json":"https://secwatch.observer/filing/0001830214-25-000009.json","markdown":"https://secwatch.observer/filing/0001830214-25-000009.md","text":"https://secwatch.observer/filing/0001830214-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000183021425000009/0001830214-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000183021425000009/dna-20250904.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:21:10.007899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}